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In 1978, Sohar et al. described a strikingly peculiar syndrome in two Israeli sisters. These young women responded
to environmental temperatures of 18C–7C with profuse sweating on large segments on their back and chest. Both
had additional abnormalities, including a high-arched palate, nasal voice, depressed nasal bridge, inability to fully
extend their elbows, and kyphoscoliosis. We have observed this disorder in two Norwegian brothers. Genomewide
screening in the two families, followed by saturation marker studies and linkage analysis, identified a 1.4-Mb
homozygous candidate region on chromosome 19p12. The maximum multipoint LOD score was 4.22. In both
families, DNA sequencing of 25 genes within the candidate region identified potentially deleteriousCRLF1 sequence
variants that were not found in unaffected control individuals. Our findings confirm that the cold-induced sweating
syndrome is an autosomal recessive disorder that is probably caused by impaired function of the CRLF1 gene, and
they suggest important developmental functions for human CRLF1.
Introduction
The cold-induced sweating syndrome (CISS [MIM
272430]) was first described by Sohar et al. (1978).
Two Israeli sisters experienced profuse sweating, in-
duced by cool surroundings, on large segments of their
back and chest. They also had some additional abnor-
malities, including a high-arched palate, nasal voice,
depressed nasal bridge, inability to fully extend their
elbows, and kyphoscoliosis. Their parents shared a com-
mon grandfather, suggesting that the observed condition
represented a novel syndrome inherited as an autosomal
recessive trait. Since this initial description, no confirm-
ing case of CISS with reference to the original publica-
tion has been described. Thus, the reported disorder is
probably very rare.
We have observed a clinical phenotype in two Nor-
wegian brothers that is similar to the one described
in the Israeli sisters. No parental consanguinity was
known, but genealogical studies revealed several shared
ancestors, the closest of which was found nine gen-
erations back. Thus, also in the affected Norwegian
brothers, homozygosity for a mutant gene inherited
from a common ancestor constituted a likely mech-
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anism for this disorder. Exploiting this unique situa-
tion, we employed a combination of coarse-scale homo-
zygosity mapping, based on the Israeli inbred sibship
with a common great-grandfather, and finer-scale lo-
calization, based on the Norwegian sibship with dis-
tant common ancestors. Thus, on the basis of only four
patients, we have identified the candidate chromoso-
mal segment, the candidate gene, and the likely caus-
ative mutations.
Material and Methods
Genotyping
Genomic DNAwas isolated fromwhole blood by using
an ABI 341 Nucleic Acid Extractor (PE Applied Biosys-
tems). A genomewide scan was performed using a set of
400 microsatellite markers with an average spacing of
10 cM (ABI Prism Linkage Mapping Set MD, version
2). PCR and pipettingwere performed using theABICata-
lyst 800 Turbo Lab station. The PCR products were an-
alyzed using an ABI 310 Genetic Analyzer and the Gene-
scan Analysis software (PE Applied Biosystems). High-
density mapping was performed by employing markers
identified in various databases (see the GenLink, Coop-
erative Human Linkage Center, Entrez Genome, Genome
Database, and Center for Medical Genetics, Marshfield
Medical Research Foundation, Web sites). On the basis
of chromosome 19 draft sequences from Lawrence Liv-
ermore National Laboratories (see the LLNL Human
Genome Center Web site), anonymous repeated (CA)
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sequences were identified, primers were constructed,
and amplified fragments were probed for variants in
the Norwegian nuclear family. The PCR primer se-
quences and population heterozygosity frequencies of
these markers are given in table A (online only).
Linkage Analysis
Two-point and multipoint linkage analyses were per-
formed using the Mlink and Linkmap programs of the
Fastlink software package (Cottingham et al. 1993).
Initially, single-point LOD scores were used to identify
all regions consistent with a recessive pattern of inheri-
tance in both families. Those regions were then subjected
to fine mapping with additional genetic markers. After
identification of the candidate region on chromosome
19p12, multipoint analysis (limited to three markers by
running time of the software) was performed, to deter-
mine the statistical significance of the finding. We used a
disease-allele frequency of 0.001 and penetrances of 0 for
carriers and noncarriers and 0.99 for homozygous af-
fected individuals. In the initial genome scan, equal allele
frequencies were assumed, but, for the fine mapping in
the Norwegian family, allele frequencies were determined
in 50 unaffected Norwegian control individuals. We also
used a method based on the theoretical work of Durham
and Feingold (1997), to estimate the probability that the
homozygosity observed in the Norwegian pedigree is a
false positive (i.e., a chance occurrence, not caused by
linkage to the disease locus). We applied equations 1 and
4 of Durham and Feingold (1997) and considered all in-
breeding loops of different lengths to be independent, re-
sulting in a conservative P value.
DNA Sequencing and Mutation Detection
PCR primers for amplification of exons and flanking
intron sequences in the 1.4-Mb region were designed us-
ing the Oligo 6.3 software (Molecular Biology Insights).
PCR amplification was performed under standard con-
ditions, using AmpliTaq Gold (PE Applied Biosystems)
or Taq polymerase (Qiagen). After amplification, the PCR
products were treated with SAP/exonuclease I (Amer-
sham), were sequenced using the ABI Prism BigDye
terminator and sequencing kit version 2, and were
analyzed on an ABI 3100 Genetic Analyzer (PE Ap-
plied Biosystems). A list of our SNP findings is given
in table B (online only). Sequencing primers are avail-
able on request. DNA sequences were analyzed using
the Staden software package (Bonfield et al. 1998).
Control Samples
DNA samples were obtained from 200 ostensibly
healthy local Norwegian blood donors and 50 Israeli
matched control individuals of an ethnic background
similar to the patients.
Screening Tests for the CRLF1 Sequence Variants
The c.844_845delGT mutation was verified by PCR
amplification by forward (5′-GCAGAGGGAAGAGG-
AGGAAAACAGA-3′) and reverse (5′-CACACCACT-
ATGCGACAGAATGAG-3′) primers of exon 5 of the
CRLF1 gene, followed by analysis of the fluorescence-
labeled PCR product on an ABI 310 Genetic Analyzer.
The R81H mutation destroys a naturalHhaI restriction
site in exon 2 of the CRLF1 gene, and this formed the
basis for a rapid screening for this mutation. Exon 2
of the CRLF1 gene was PCR amplified using the exon
2 forward (5′-ATTTAACCCAACTGATCTCTACCTT-
3′) and reverse (5′-TGAAAGACCTGCATAGCCAT-3′)
primers, followed by digestion by HhaI and separation
on an 3% Nusieve agarose gel (FMC). HhaI digestion
of the PCR-amplified products from normal chromo-
somes gives two bands (286 and 290 bp), whereas no
cutting of the PCR product amplified from mutant
chromosomes was observed. We found no simple way
of detecting L374R, and a search for this variant was
performed by sequencing the proper exon.
Clinical Findings
A brief clinical description of the Israeli sisters has been
given elsewhere (Sohar et al. 1978). Both sisters noted the
cold-induced sweating at age 16–17 years, shortly after
menarche. Their problem has now persisted unchanged
for 25 years. The sweating reaction to cold exposure al-
ways starts at the same point, in the presternal region in
one and in the left hand in the other. It quickly spreads
to the rest of the affected areas, distributed as patches,
above the waist, on the chest and back. In the affected
areas, no sweating occurs at warm temperatures or during
febrile episodes. No medical treatment or remedy has so
far been helpful in relieving this socially embarrassing
disorder. Renewed x-ray examinations show that both
sisters have thoracolumbar scoliosis, moderate (30–35)
in the older sister and less pronounced in the younger
sister. Neither of these patients had feeding difficulties in
the newborn period. Both sisters have four children, none
of whom are affected with this disorder.
The Norwegian brothers were born at term, after
uneventful pregnancies. The older would not suckle
in the neonatal period and was admitted, dehydrated,
to the hospital at 5 d old. He was fed first by a na-
sogastric tube and subsequently by a special sucking
device intended for newborn lambs. Because of con-
tinued severe feeding problems, complicated by bron-
chopulmonary and urinary tract infections, he was
treated in the neonatal ward for 3 mo. His younger
brother was admitted at 1 d old, primarily because of
respiratory problems. Also, this newborn baby did not
suckle spontaneously and had to be fed in ways similar
to those used for his older brother. Both have problems
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with fully opening their mouths, rendering ordinary
dental work difficult. While playing in the snow, the
older brother has repeatedly experienced frostbite in
his hands, which was, on one occasion, severe, requir-
ing professional treatment. Likewise, he can hold his
palms in a flame or put his hands in boiling water
without any sensory pain.
Both of these Norwegian boys have severe progressive
kyphoscoliosis. In the younger brother, an S-shaped sco-
liosis rapidly progressed over a period of 6 mo, at age 13
years. At that time, the major curve measured 47, and
the kyphosis measured 70 (Cobb angle [Cobb 1948]).
Posterior-spine surgery was performed, the deformitywas
corrected, and thoracic vertebrae 3–11 were fused. How-
ever, with time, severe kyphosis developed above the fused
part. The older brother was first seen by an orthopedic
surgeon at age 18 years. He then had both a severe ky-
phosis (Cobb angle 90) and scoliosis that was somewhat
less pronounced. Also, this patient underwent spine sur-
gery, but a combined anterior and posterior approachwas
chosen because of severe stiffness. Posterior instrumen-
tation was done, and fusion between thoracic vertebrae
2 and 12 was achieved with satisfactory correction.
The procedures performed on these brothers are con-
sidered to be very painful in the postoperative period.
However, it was noted that the boys had unusually low
demand for pain-relieving medication and seemingly
were not bothered by the postoperative pain. During
surgery on the older brother, the surgeon noted unusu-
ally lightly colored muscle (“like chicken meat”). A
biopsy was performed, and the finding was described
as “muscular atrophy.”
Both brothers have short hands with pronounced clino-
dactyly and tapering of fingers. They cannot fully extend
their elbows (30 deficit). Also, their toes are somewhat
short, and both have flat feet. They have insufficient
activity of facial muscles, leading to expressionless
faces; instead of a smile, a grin results. Their sweating
problem was noted at ∼7 years of age. The patchwise
distribution of affected areas much resembles those de-
scribed in the Israeli sisters. These areas do not sweat
at warm temperatures, during fever episodes, or during
exercise. The mother sometimes had to cool her over-
heated children by putting their feet in cold water. Sub-
tropical environment does not bother these patients.
They can stay in bright sunlight without feeling the heat
and have no desire to take their clothes off for cooling.
Genealogical Studies
Until the 20th century, the majority of the Norwegian
population was attached to a single locality throughout
life. A cumulative population-inbreeding coefficient has
been estimated at 0.0027 (Gedde-Dahl 1973). Many ru-
ral communities in Norway have produced printed local
histories, often including volumes of painstakingly
gathered genealogical data for each farm, back to the
first church records and censuses (17th century). For
communities without such printed sources, online data
from national censuses and church records were used
(see the Digitalarkivet Web site). These tools made it
possible to identify, by name, all of theNorwegian broth-
ers’ 32 ancestors, five generations back, all of whom
were born in the first half of the 19th century. All an-
cestral lines were pursued as far back as possible. Of the
16 ancestors in each line, 3 in the paternal line and 8
in the maternal line originated from the same rural com-
munity. It was possible to trace the majority of these
ancestral branches back to the 17th century, and it was
possible to trace some branches even further back. The
first common ancestor was identified nine generations
back (fig. 1A, indicated by the arrow). Another five, six,
three, two, and one new common ancestral couples were
identified 10, 11, 12, 13, and 14 generations back, re-
spectively. Nearly 1,000 ancestors were identified by
name, and a very complex pedigree emerged.
Results
Linkage Analysis
When genomewide screening was performed, using
markers with an average spacing of 10 cM, three pos-
sible candidate regions could not readily be excluded.
Ambiguous results owing to limited heterozygosity
were obtained in regions on chromosomes 3q and 21.
The results of a total of 12 additional markers, dis-
tributed between the screening markers, excluded these
regions as true candidates. However, on chromosome
19, the Israeli sisters and the Norwegian brothers had
inherited, from their parents, a pair of common seg-
ments spanning !60 Mb and !48 Mb, respectively (ta-
ble 1). Within the 42-Mb overlapping candidate seg-
ment, the Israeli sisters were homozygous for only two
nonadjacent markers, D19S221 and D19S414. Ho-
mozygosity was not observed for any of the initial
screening markers in this region (D19S221-D19S414)
in the Norwegian sibship. Detailed mapping of this
region showed that the two Israeli sisters were ho-
mozygous for a segment, encompassing 28.8 Mb, that
was not revealed by the screening markers (fig. 1 and
table 1). Markers D19S221 and D19S414 were both
positioned outside this segment. Subsequently, satura-
tion marker studies, as well as SNPs detected by DNA
sequencing, demonstrated a 1.4-Mb region of homo-
zygosity within the candidate segment in the Norwe-
gian brothers (fig. 1 and table 1).
We performedmultipoint linkage analysis, to determine
Table 1
Genotypes of Chromosome 19 Markers
GENOTYPEb IN PEDIGREE
MARKERa X-1 X-2 XI-1 XI-2 III-2 IV-1 IV-2 IV-3 IV-4 IV-5
D19S209 251 251 247 243 251 243 251 247 246 250 248 250 248 250 244 246 248 250 244 250
D19S216 265 269 271 267 265 271 265 271 259 265 265 265 267 265 265 259 267 265 265 265
D19S884 107 97 107 107 107 107 107 107 103 107 91 107 97 107 97 103 97 107 91 107
D19S221 88 104 104 106 88 104 88 104 98 98 93 98 98 98 98 98 98 98 93 98
D19S226 254 254 246 250 254 246 254 246 240 254 254 254 238 254 238 240 238 240 254 254
D19S929 251 253 251 253 251 251 251 251 253 249 251 249 249 249 249 253 249 253 251 249
D19S841 245 245 235 235 245 235 245 235 247 243 235 243 243 243 243 247 243 247 235 243
D19S588 162 148 170 170 162 170 162 170 149 149 149 149 166 149 166 149 166 149 149 149
D19S244 138 109 126 99 138 126 138 126 101 105 105 105 90 149 90 101 90 101 105 105
D19S930 181 196 183 181 181 183 181 183 187 183 198 183 189 149 189 187 189 187 198 183
D19S899 102 109 104 112 102 104 102 104 103 105 101 105 107 149 107 103 107 103 101 105
D19S410 155 168 173 155 155 173 155 173 162 154 154 154 171 149 171 162 171 162 154 154
D19S579 163 179 179 171 163 179 163 179 175 175 175 175 171 149 171 175 171 175 175 175
D19S429 231 235 239 231 235 239 235 239 231 231 231 231 235 149 235 231 235 231 231 231
D19S915 109 101 107 111 109 107 109 107 89 109 89 109 107 149 107 89 107 89 89 109
D19S1037 119 119 123 123 119 123 119 123 115 131 135 131 115 149 115 115 115 115 135 131
D19S212 193 197 193 205 193 193 193 193 197 205 193 205 197 149 197 197 197 197 193 205
D19S460 128 130 128 122 130 128 130 128 128 122 130 122 128 149 128 128 128 128 130 122
D19S898 174 184 190 180 174 190 174 190 190 179 177 179 190 149 190 190 190 190 177 179
M6A 196 212 202 198 196 202 196 202
M5A 187 117 201 203 187 201 187 201
M1A 245 247 245 237 245 245 245 245
M3A 228 230 228 220 228 228 228 228
D19S895 127 122 127 127 127 127 127 127 131 123 133 123 131 123 131 131 131 131 133 123
M4A 170 177 170 170 170 170 170 170
D19S566 154 160 154 156 154 154 154 154 154 142 156 142 154 142 154 154 154 154 156 142
D19S443 128 128 128 128 128 128 128 128 126 126 126 126 126 126 126 126 126 126 126 126
D19S603 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136 136
M1 185 185 185 185 185 185 185 185
M2 156 158 156 158 156 156 156 156
M3 163 165 163 165 163 163 163 163
M5 201 189 201 201 201 201 201 201
M4 170 177 170 170 170 170 170 170
M6 188 186 186 184 188 186 188 186
D19S546 314 314 314 314 314 314 314 314 314 284 314 284 314 284 314 314 314 314 314 284
D19S407 209 209 216 216 209 216 209 216 202 210 210 210 202 210 202 202 202 202 210 210
M8 155 148 153 148 155 153 155 153
D19S911 231 231 225 231 231 225 231 231 231 227 229 227 231 227 231 231 231 231 229 227
D19S602 103 105 109 103 103 109 103 103 109 103 115 103 109 103 109 109 109 109 115 103
D19S925 262 266 266 268 262 266 262 268 266 262 266 262 266 262 266 266 266 266 266 262
D19S215 259 243 249 257 259 249 259 257 243 257 249 257 243 257 243 243 243 243 249 257
D19S910 239 251 239 239 239 239 239 239 239 239 237 239 239 239 239 239 239 239 237 239
D19S401 353 353 345 341 353 345 353 341 345 349 353 349 345 349 345 345 341 345 353 349
D19S568 256 246 256 268 256 256 256 268 246 246 256 246 246 246 246 246 246 246 256 246
D19S434 269 273 273 269 269 273 269 269 270 278 270 278 270 278 270 270 270 270 270 278
D19S1036 208 208 208 204 208 208 208 204 208 204 204 204 208 204 208 208 208 208 204 204
Centromere
D19S419 165 167 167 163 165 167 165 163 165 165 165 165 165 165 165 165 165 165 165 165
D19S931 159 161 157 157 159 157 159 157 156 160 164 160 156 160 156 156 156 156 164 160
D19S870 256 251 256 251 256 256 256 251 251 256 251 256 251 256 251 251 251 251 251 256
D19S222 231 231 231 231 231 231 231 231 239 237 237 237 239 237 239 239 239 239 237 237
D19S920 213 213 209 209 213 209 213 209 209 213 209 213 209 213 209 209 209 209 209 213
D19S932 141 129 137 135 141 137 141 135 129 135 129 135 129 135 129 129 129 129 129 135
D19S875 91 111 105 103 91 105 91 103 107 109 91 109 107 109 107 107 107 107 91 109
D19S919 213 209 209 209 213 209 213 209 209 209 211 209 207 209 207 209 207 209 211 209
D19S433 196 196 200 215 196 200 196 215 213 203 199 203 213 203 213 213 213 213 199 203
(continued)
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Table 1 (continued)
GENOTYPEb IN PEDIGREE
MARKERa X-1 X-2 XI-1 XI-2 III-2 IV-1 IV-2 IV-3 IV-4 IV-5
D19S405 113 115 107 115 113 107 113 115 113 113 111 113 113 113 113 113 113 113 111 113
D19S882 279 277 279 267 279 279 279 267 279 279 267 279 279 279 279 279 279 279 267 279
D19S414 181 167 167 167 181 167 181 167 186 184 182 184 186 184 186 186 186 186 182 184
D19S225 173 173 167 171 173 167 173 171 169 175 171 175 169 175 169 169 169 169 171 175
D19S868 194 198 198 198 194 198 194 198 179 190 190 190 179 190 179 179 179 179 190 190
D19S416 168 170 166 172 168 166 168 172 168 168 168 168 168 168 168 168 168 168 168 168
D19S425 251 259 271 251 251 271 251 251 251 261 251 261 265 261 265 251 265 251 251 261
D19S224 249 233 233 251 249 233 249 251 251 253 251 253 251 253 251 251 251 251 251 253
D19S220 283 289 279 285 283 279 283 285 289 279 281 279 279 279 279 289 279 289 281 279
D19S420 110 90 100 106 110 100 110 106 106 98 110 98 94 98 94 106 94 106 110 98
D19S902 259 244 250 240 259 250 259 240 249 249 239 249 239 249 239 249 239 249 247 249
D19S571 287 287 287 313 287 287 287 313 310 310 310 310 310 310 310 310 310 310 310 310
D19S418 96 92 92 86 96 92 96 92 90 90 90 90 90 90 90 90 90 90 90 90
D19S877 250 244 240 242 250 240 250 240 261 261 240 261 261 261 240 261 240 261 240 261
D19S254 140 132 112 112 132 112 140 112 112 132 112 132 128 132 128 132 112 112 112 112
D19S210 177 185 177 179 177 177 177 177 177 175 175 175 177 175 175 177 177 177 177 175
D19S890 278 280 282 274 280 282 278 274 280 280 276 280 288 280 288 280 276 280 276 280
a Markers are ordered according to NCBI Map Viewer, build 30 (see the Entrez Genome Web site). ABI screening kit markers are underlined;
the markers beginning with “M” were established in our laboratory (for details, see table A).
b Regions of homozygosity are boxed. Boldface italic numerals refer to the shared chromosomal segments in the Norwegian brothers; roman
numerals refer to the pedigrees in figure 1.
the statistical significance of the observed homozygosity.
For the Israeli family, themaximummultipoint LODscore
within the shared segment was 2.47. Unfortunately, the
complexity of the Norwegian pedigree imposed compu-
tational constraints, limiting the analysis to three markers
at a time. Within the Norwegian family, we obtained a
maximum four-point LOD score of 1.75, on the basis of
markers D19S895, D19S566, and D19S603. In the ab-
sence of ancestral genotypes, this is an underestimate of
the true LOD score (see the “Discussion” section).Hence,
we used the method of Durham and Feingold (1997) to
directly estimate the probability that, in the Norwegian
pedigree, we would find such an identical-by-descent
(IBD) segment by chance (i.e., without linkage to the dis-
ease locus). We estimate this genomewide probability as
. This value is statistically significant by itself,p ! 0.02
and the LOD score of 4.22 for the two families combined
further supports the significance of the finding.
Identification and DNA Sequencing of Candidate
Genes
Chromosome 19 is unusually gene rich. More than
50 confirmed and hypothetical genes reside within this
1.4-Mb candidate region (NCBI Map Viewer, build 30
[see the Entrez Genome Web site]). No detrimental mu-
tations were detected in the coding sequences of the first
24 sequenced genes (table B).
Eventually, DNA sequencing of the cytokine receptor–
like factor 1 gene (CRLF1) identified homozygosity for a
2-bp deletion (c.844_845delGT) in exon 5 of the CRLF1
gene in the Norwegian brothers (fig. 2A). Such a frame-
shift mutation will result in a nonfunctional gene product.
In the Israeli sisters, homozygosity for two sequence var-
iants was demonstrated, in codons 81 (CGCrCAC) and
374 (CTCrCGC) (figs. 2B and 2C). Each substitution
is predicted to produce amino acid an change, R81H
and L374R, respectively. Neither the deletion nor the
substitutions were identified among 200 Norwegian and
50 Israeli control individuals, supporting the assumption
that these mutations are causally related to the disorder.
To investigate whether sequence variants in theCRLF1
gene could be commonly encountered in the population,
we sequenced the nine exons of the CRLF1 gene in 10
unaffected Norwegian blood donors. No variants were
found.
We also sequenced the coding sequence of the function-
ally related CNTF gene in all four patients, to investigate
whether a variant in this gene could influence the CISS
phenotype. A predicted serinerglycine variant in CNTF
codon 208 (i.e., heterozygous S208G) was identified in
both Norwegian brothers. This sequence variant rep-
resents a common polymorphism in the Norwegian
population (allele frequency 0.27). No sequence vari-
ants were identified in the Israeli sisters.
Discussion
Our study demonstrated a 1.4-Mb candidate region of
homozygosity (IBD) in the Norwegian patients. Be-
Figure 1 Pedigree of Norwegian (A) and Israeli (B) families. Blackened symbols indicate patients with CISS. In the Norwegian family, the first common ancestor was found nine generations
back (arrow). Observed marker homozygosity is shown in boldface.
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Figure 2 Mutation analysis of CRLF1 in Norwegian and Israeli
families. Wtp wild type. A,DNA sequence of CRLF1 exon 5, showing
the 2-bp deletion (c.844_845delGT). B, DNA sequence of CRLF1 exon
2, showing the ArG substitution in the second position of codon 81,
predicting a change from arginine to histidine (R81H).C,DNAsequence
of CRLF1 exon 7, showing the TrG substitution in the second position
of codon 374, substituting arginine for leucine (L374R). The sites of
mutational changes are indicated by asterisks (*). (Numbering ofCRLF1
cDNA here is based on GenBank [accession number NM_004750.2].)
cause of computational constraints, we were not able
to calculate an exact multipoint LOD score for the
Norwegian pedigree. In the absence of ancestral ge-
notypes, the probability that a shared segment is in-
herited IBD from a common ancestor increases with
the number of informative markers contained in the
segment; that is, a shared segment containing only three
markers has a significant probability of being simply
identical by state, whereas a segment containing a large
number of shared markers is much more likely to be
IBD from a common ancestor. Thus, the maximum
four-point LOD score of 4.22 for the two families com-
bined, on the basis of only three markers from within
an interval containing 13 shared markers, is an un-
derestimate of the true LOD score. As an alternative
approach, we adapted the method of Durham and Fein-
gold (1997) to estimate the probability that the ho-
mozygosity observed in the Norwegian pedigree is a
false positive. We estimate this probability as .p ! 0.02
Both of the above approaches provide strong support
for the hypothesis that the shared segment on chro-
mosome 19 contains the disease locus.
DNA sequencing of the CRLF1 gene identified mu-
tations in both the Norwegian brothers and the Israeli
sisters. The 2-bp deletion observed in the Norwegian
brothers will result in a frameshift encoding a non-
functional gene product. The substitutions observed in
the Israeli sisters are predicted to produce the amino
acid changes R81H and L374R. Although the overall
phenotype in the Norwegian brothers and the Israeli
sisters was similar, the phenotype in the brothers was
more severe (e.g., including feeding difficulties, serious
kyphoscoliosis, earlier age at onset of the sweating
problem, and reduced pain and temperature sensitiv-
ity). These differences may be related to different de-
grees of functional severity of the observed CRLF1
mutations—namely, a knockout mutation in the Nor-
wegian brothers and the presence of a CRLF1 protein
that may have some residual activity in the Israeli sis-
ters. Possibly, other genetic factors (e.g., different sex
of the patients) may have also contributed.
CRLF1 is a soluble cytokine receptor with homology
to type 1 cytokine receptors (Elson et al. 1998). CRLF1
associates with the cardiotrophin-like cytokine, to form
a soluble functional heteromeric ligand, and competes
with ciliary neurotrophic factor (CNTF) for the binding
to the ciliary neurotrophic factor receptor (CNTFR)
complex (Elson et al. 2000). The binding of CRLF1
and CNTF to a common receptor—and their appar-
ent functional similarity—led to the dubbing of CRLF1
as “CNTF II” (Lesser and Lo 2000). CNTF exerts a
survival-promoting effect on a variety of neuronal cells.
However, the use of CNTF as an experimental treatment
of patients with motor-neuron disease did not influence
the clinical course of this degenerative disorder (Lam-
bert et al. 2001). Furthermore, a null mutation in the
CNTF gene occurs as a common variant in the Japanese
population and is not associated with any neurological
disorder (Takahashi et al. 1994).
To our knowledge, no impaired function of either
CRLF1 or any of the other factors constituting the
CNTFR complex has so far been implicated in any
human disorder. However, some clinical observations
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in the Norwegian brothers show similarities to obser-
vationsmade in experimental animals and in cell cultures.
In the developing mouse embryo, CRLF1 is expressed at
multiple sites, including skeletal muscle (Elson et al.
1998; Alexander et al. 1999). CNTFR, the receptor for
CRLF1, is primarily expressed in the nervous system
(Stockli et al. 1991; DeChiara et al. 1995), but expression
is also detected in skeletal muscle (Davis et al. 1991). A
muscle biopsy performed during back surgery in one of
the Norwegian patients showed atrophic skeletal muscle,
possibly contributing to the development of his severe
kyphoscoliosis. This may indicate that normal CRLF1
exerts an effect not only on neuronal but also on skeletal-
muscle development and survival.
In vitro experiments show that CRLF1 can promote
the survival of developing embryonic motor neurons (El-
son et al. 2000).Mousemodels lacking either theCRLF1,
CNTFR, or CNTF function have been constructed. A
significant reduction in motor-neuron numbers in brain
motor nuclei and in the spinal cord has been observed
in mice that lack CNTFR (DeChiara et al. 1995), but no
structural anomalies have been observed inmice that lack
CNTF (Alexander et al. 1999). The metal used for ver-
tebral fixation in the Norwegian boys precludes renewed
magnetic-resonance–imaging studies. However, the pre-
operative images of the cervicothoracic spine show ap-
parently normal dimensions of the spinal cord in both
brothers.
Mice lacking the CRLF1 gene (i.e., NR6/mice) were
unable to suckle and died of starvation shortly after birth,
with their stomachs devoid of milk (Alexander et al.
1999). The newborn mice could open and close their
mouths, and no anatomical anomalies were detected
on dissection. Alexander et al. (1999) concluded that
CRLF1 was indispensible for suckling, but they were
unable to identify the mechanism by which its role was
mediated. They have put forth a hypothesis that in-
volves either (a) defective recognition or processing of
pheromonal signals or (b) defective mechanics of suck-
ling itself. Also, newborn mice that lack CNTFR are
unable to feed; in these mice, impaired jaw movements
have been observed.
Both Norwegian patients (but not the Israeli patients)
had severe feeding problems as newborns, requiring
hospitalization and nasogastric feeding. As children, the
brothers continued to show no interest in food. They
made many excuses to avoid eating and lagged behind
in their growth and development. They both have re-
stricted jaw movements, making dental work difficult,
but physical restraint is not a major reason for them
not to eat. Interestingly, injections of the related CNTF
can cause weight loss in animals and humans, likely to
work via a leptinlike pathway on appetite centers in the
hypothalamus (Lambert et al. 2001). Thus, it is tempt-
ing to speculate that the potentially lethal lack of ap-
petite exerted by a knockout mutation in the CRLF1
gene may also, in some way, be mediated through mal-
function of appetite-regulation centers.
One possibility is that there is normally a physiolog-
ical competitive binding of CNTF and CRLF1 to their
common receptor, CNTFR, at various stages in devel-
opment (Elson et al. 2000). In the Norwegian patients
with a CRLF1-knockout mutation, the postulated nor-
mal balance between the two ligands competing for the
same receptor could be impaired. Since no CRLF1 is
produced, their common receptor may be stimulated
solely by CNTF, exerting a potentially lethal appetite-
depressive effect. Interestingly, leptin has recently been
shown to act as a skeletal growth factor, with a direct
peripheral effect on the mouse mandibular growth cen-
ter through a mechanism that is as yet unknown (Maor
et al. 2002).
Response to cold is a complex interplay of ion channels
in both cold-sensitive and cold-insensitive neurons (Viana
et al. 2002). Information on gentle cooling is transmitted
by a small subpopulation of sensory nerves, whereas
others transmit information on noxious cold and pain.
Small changes in the balance of channel expression or
in the properties of cold-insensitive neurons may trans-
form cold-insensitive neurons into cold-sensitive fibers
(McMemy et al. 2002; Peier et al. 2002; Viana et al.
2002). In all four patients with CISS, the parts of the
body surface that sweat profusely at cold temperatures
were completely dry under circumstances that normally
induce sweating (e.g., hot weather, strenuous exercise,
and fever). Thus, the sweat glands in the implicated
parts of the body remain under neural control but react
inversely to environmental temperatures. The Norwe-
gian patients have impaired peripheral sensitivity to
pain and temperature, including the direct exposure to
subfreezing cold and steaming heat. Thus, further stud-
ies of patients with the CRLF1-deficient phenotype may
yield information on complex neuronal processing and
the interrelationship between various sensory stimuli.
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